Mia's Feed
Medical News & Research

Fasting Impacts Metabolism and Immune Function Differently in Individuals with Obesity

Fasting Impacts Metabolism and Immune Function Differently in Individuals with Obesity

Share this article

New research shows that fasting influences metabolism and immune responses differently in people with obesity compared to lean individuals, highlighting the need for personalized dietary approaches.

2 min read

Fasting has gained popularity as a method for weight loss and health improvement, but new research from the University of British Columbia indicates that its effects vary significantly depending on body type. Particularly, individuals with obesity respond differently to fasting compared to lean individuals, especially regarding immune system activity and metabolic changes.

The study focuses on the common practice of fasting, often in conjunction with ketogenic, very low-carbohydrate diets aimed at promoting fat burning through ketone production. Dr. Hashim Islam, an assistant professor at UBCO, explains that while fasting and low-carb diets can be beneficial for many, they may produce different outcomes in those living with obesity.

Fasting is believed to push the body from burning sugar to burning fat, creating ketones that can potentially fortify immune health and decrease chronic inflammation—a common link to many chronic diseases. However, the recent investigation revealed that in people with obesity, this shift is less pronounced. Participants with obesity showed sustained levels of pro-inflammatory T cells and produced inflammatory signals even after fasting, unlike lean participants whose immune cells adapted by increasing fat burning and generating more ketones.

Researchers measured various biological markers, including hormones, metabolites, and white blood cell activity, at different stages during a 48-hour fast. The findings, published in iScience, indicated that while fasting prompts lean individuals to shift towards an anti-inflammatory state, this response is weaker and less effective in those with obesity.

Dr. Helena Neudorf, the lead author, highlights that immune responses in lean participants became more balanced and anti-inflammatory. Conversely, people with obesity experienced increased inflammation and less metabolic flexibility, with smaller rises in ketone levels and reduced immune regulation. Dr. Islam stresses that although fasting can yield health benefits, obesity appears to dampen its positive effects.

The research underscores a complex relationship between nutrition, immune function, and metabolism, suggesting that fasting’s benefits may be limited or altered in individuals with obesity. More studies are needed to understand whether fasting could serve as a therapeutic strategy tailored to different body types and health conditions.

Source: [https://medicalxpress.com/news/2025-08-fasting-affect-metabolism-immune-response.html]

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Michigan Court Strikes Down 24-Hour Abortion Waiting Period Following Voter-Backed Amendment

A Michigan judge has struck down the state's 24-hour waiting period for abortion, affirming reproductive rights protected by the 2022 constitutional amendment and removing restrictive regulations.

Advancements in Understanding the Most Aggressive Form of Prostate Cancer

New research uncovers the unique biological features of metastatic prostate cancer, providing critical insights into its aggressive behavior and potential avenues for targeted treatment.

The Crucial Role of Psychologists in End-of-Life Care and Voluntary Assisted Dying in Australia

New research highlights the vital role psychologists could play in supporting end-of-life and voluntary assisted dying in Australia, addressing current barriers and policy gaps.

Innovative Implantable Device Aims to Prevent Life-Threatening Low Blood Sugar in Diabetes Patients

MIT researchers have developed an innovative implantable device that automatically releases glucagon to prevent life-threatening hypoglycemia in diabetes patients, offering a new approach to emergency treatment.